Abstract:Objective To study the effect of cysteine-rich protein 61 (CYR61) on the proliferation and cell cycle of endometrial cancer (EC) cell line HEC-1B, and to explore the possible mechanism.Methods Log phase HEC-1B cells were taken and randomly divided into control group (no treatment), pcDNA3.1-NC group (transfected with pcDNA3.1-NC), pcDNA3.1 CYR61 group (transfected with pcDNA3.1 CYR61), pcDNA3.1 CYR61 + LiCl [Wnt/β-catenin (β-catenin) pathway activator] group (pcDNA3.1 CYR61 was transfected, and LiCl was added to make the final concentration 60 mmol/L). At 48h after transfection, the proliferation inhibition rate was detected by MTT experiment. The cycle proportion was detected by PI staining method. The protein expression level of β-catenin, aspartate-specific caspase-3 (Caspase-3), and Cyclin D1 (Cyclin D1) in different groups were detected by Western blotting method.Results Compared with control group and pcDNA3.1-NC group, the proportion of S, G2/M phase, and the protein expression of β-catenin, Caspase-3, Cyclin D1 in the pcDNA3.1 CYR61 group were decreased, and the CYR61 protein expression and the proportion of G0/G1 phase was increased (P < 0.05). Compared with pcDNA3.1 CYR61 group, the proportion of S, G2/M phase, and the protein expression of β-catenin, Caspase-3, Cyclin D1 in the pcDNA3.1 CYR61 + LiCl group were increased, and the CYR61 protein expression, the proportion of G0/G1 phase was decreased (P < 0.05). The proliferation inhibition rates of pcDNA3.1-NC group, pcDNA3.1 CYR61 group, and pcDNA3.1 CYR61 + LiCl group were different (F = 46.962, P = 0.000). The pcDNA3.1 CYR61 group had higher proliferation inhibition rate and better proliferation inhibition effect. There were differences in the change trend of proliferation inhibition rate among pcDNA3.1-NC group, pcDNA3.1 CYR61 group, and pcDNA3.1 CYR61 + LiCl group (F = 37.541, P = 0.000).Conclusion Up-regulation of CYR61 can inhibit the proliferation of EC cell line HEC-1B and block its cell cycle, which may be achieved by inhibiting the Wnt/β-catenin signaling pathway.